
An overview of today's top infectious disease stories.
Patrick Soon-Shiong, MD, CEO of ImmunityBio, discusses the pandemic as a unique moment in world & American history.
Thomas File, Jr. MD, MSc, FIDSA, president of the Infectious Diseases Society of America, weighs in on COVID vaccine development, fears of a second wave, and treatment candidates.
A video summary of the latest infectious disease headlines.
A June 19, 2020 recap of the biggest headlines in pandemic research and response.
Steven Woloshin, MD, MS, discusses a recently authored article in the New England Journal of Medicine describing the challenges and implications of false negative tests for SARS-CoV-2 infection.
A video review of the latest ID news.
Vibeke Strand, MD, MACR, FACP, of the Division of Immunology/Rheumatology at Stanford University School of Medicine, discusses ongoing AI research in her field.
An overview of 3 recent infectious disease news stories.
Vibeke Strand, MD, MACR, FACP, discusses patients who are having a hard time getting their usual supplies of HCQ.
Given there is not a clear international standard for health records, one of the challenges in the early COVID-19 response mobilization was a delayed start to data collection and indexing.
Some countries have been proactive in patient logging and tracking. How can even retroactive assessment benefit future preventive responses?
A look at 3 major headlines in COVID-19 news on June 15, 2020.
Trending infectious disease news.
A brief on today's top ID stories.
Patrick Soon-Shiong, MD, describes goals and expectations for the accelerated coronavirus vaccine program Operation Warp Speed.
A brief update on today's infectious disease news.
Patrick Soon-Shiong, MD, explains why an ImmunityBio SARS-CoV-2 vaccine candidate uses Nucleocapsid DNA alongside Spike DNA.
A quick brief on today's top infectious disease news.
Mary Schmidt, MD, discusses challenges in translating infectious disease advice to policy action.
Jason Pogue, PharmD, BCPS, BCIDP, speaks about the state of publishing during the COVID-19 pandemic.
A brief on today's top ID news.
Jason Pogue, PharmD, BCPS, BCIDP, answers questions about the emerging picture for hydroxychloroquine.
John Strotbeck, CEO of Boathouse Sports, discusses results of physical distancing measures at the firm's COVID-adapted factory.
Adam Brufsky, MD, PhD, addresses the potential for changing dynamics in SARS-CoV-2.
A brief on the latest infectious disease headlines.
Matthew F. Pullen, MD, co-author of the recent hydroxychloroquine prophylaxis trial, shares the top clinical takeaways.
Why people may need to readjust their expectations around COVID-19 clinical data and drugs.
John Strotbeck, Olympian and CEO of Boathouse Sports, explains how and why the outerwear company pivoted to PPE production at the start of the COVID-19 pandemic.
A review of the latest infectious disease news.